Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1998
12/30/1998CN1203531A Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (GDNF) protein product
12/30/1998CN1203530A Treatment of CNS effect of HIV with VX-475, alone or in combination with AZT or 3TC
12/30/1998CN1203529A 'Gamma'-RAR antagonist ligand or 'alpha'-RAR agonist ligand as apoptosis inhibitor
12/30/1998CN1203528A Use of gamma-RAR-specific agonist ligand to increase apoptosis rate
12/30/1998CN1203235A New chromene compounds, process for their preparation and pharmaceutical compositions containing them
12/30/1998CN1203234A Tricyclic pyrazol derivatives
12/30/1998CN1203232A 2-carboxymethyl-5-(5-fluoro cyti midine-1-yl) 1,3-oxythiapentane and its derivatives
12/30/1998CN1203230A N3-(5-methyl-iso-oxazole) group-3,4-dihydroxy cinnamide and producing process thereof
12/30/1998CN1203229A Sulfadiazine copper and its preparing process and medicine thereof
12/30/1998CN1203228A Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
12/30/1998CN1203227A N4-antipyrinyl-4-hydroxy-3-methoxy cinnamide and producing process thereof
12/30/1998CN1203224A Process for preparation of (1S,2R)-1-amino-2-indanol-(R,R)-tartrate methanol solvate
12/30/1998CN1203078A Process for preparing synergetic antimalarial-compound naphthoquine phosphate
12/30/1998CN1203077A Method for getting roborant and anti-senile of man and buck
12/30/1998CN1203024A Method for killing and dispelling pests with pyridazinone
12/30/1998CN1041420C Process for preparing N-acyl-2,3-benzodiazepine derivatives
12/30/1998CN1041419C Process for preparation of mitomycin C-dextran
12/30/1998CN1041418C Xanthine derivatives as adenosine A1 receptor antagonists
12/30/1998CN1041417C Sulfur-containing heterocyclic compounds, use and drug containing same
12/30/1998CN1041383C Method of preparing composition for effective depressing of woman ovulation
12/30/1998CA2594375A1 Bovine adenovirus type 3 genome
12/30/1998CA2295232A1 2,6-di-t-butyl-4-[ (dimethyl-4-methoxyphenylsilyl) -methyloxy]phenol and 2,6-di-t-butyl-4-[ (dimethyl-2-methoxy-phenylsilyl) -methyloxy]phenol
12/30/1998CA2295094A1 Method of treating heart failure
12/30/1998CA2294646A1 Human catalytic telomerase sub-unit and its diagnostic and therapeutic use
12/30/1998CA2294611A1 Complexes for transporting nucleic acid into higher eukaryotic cells
12/30/1998CA2294606A1 Soluble prodrugs of paclitaxel
12/30/1998CA2294601A1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
12/30/1998CA2294453A1 Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters
12/30/1998CA2294348A1 Vaccines containing bordetella pertussis antigen
12/30/1998CA2294283A1 Pharmaceutical composition with antiviral activity containing an hydroxymic acid derivative and an antiviral agent
12/30/1998CA2294259A1 Barbituric acid derivatives with antimetastatic and antitumor activity
12/30/1998CA2294169A1 Therapeutic method for management of diabetes mellitus
12/30/1998CA2294155A1 Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals
12/30/1998CA2294113A1 Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical preparations containing these compounds
12/30/1998CA2294050A1 New .beta.-amino and .beta.-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor antagonists
12/30/1998CA2293833A1 Compositions and methods for activating genes of interest
12/30/1998CA2293327A1 Method for the treatment of cancer with exochelins of mycobacterium tuberculosis
12/30/1998CA2292415A1 B7-binding molecules for treating immune diseases
12/30/1998CA2264022A1 Stable aspirin-containing preparations for external use
12/30/1998CA2242261A1 5-[(heteroaryl)alkyl]-3-0x0-pyrido[1,2-a]benzimidazole-4-carboxamide derivatives useful in treating central nervous system disorders
12/30/1998CA2233805A1 Use of dextran and other polysaccharides to improve mucus clearance
12/30/1998CA2209342A1 Use of dextran and other oligomeric saccharides to improve airway clearance
12/29/1998US5854382 Bioresorbable compositions for implantable prostheses
12/29/1998US5854292 Stimulating the differentiation of preadipocytic cells and therapies based thereon
12/29/1998US5854291 Pain reliever and method of use
12/29/1998US5854290 Use of guanfacine in the treatment of behavioral disorders
12/29/1998US5854289 Guanylhydrazones and their use to treat inflammatory conditions
12/29/1998US5854287 D-Propranolol metabolites useful for antioxidant activities
12/29/1998US5854286 Treatment of negative and cognitive symptoms of schizophrenia with glycine and its precursors
12/29/1998US5854285 Protein kinase inhibitor
12/29/1998US5854283 Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
12/29/1998US5854282 3-benzoyl benzofuran derivatives as thyroid hormone antagonists
12/29/1998US5854281 Preparation for percutaneous absorption
12/29/1998US5854280 Antifungal sordaridin derivatives
12/29/1998US5854279 Therapeutic agent for dermatosis
12/29/1998US5854278 Preparation of chlorinated paclitaxel analogues and use thereof as antitumor agents
12/29/1998US5854277 Thiophenebutanoic acid derivatives as matrix metalloprotease inhibitors
12/29/1998US5854273 Bisimide compounds
12/29/1998US5854272 2-alkylpyrrolidines
12/29/1998US5854271 Effective method for the amelioration and prevention of tissue and cellular damage
12/29/1998US5854270 Oral compositions containing ondansetron
12/29/1998US5854269 Nasal spray compositions
12/29/1998US5854268 Azetidine, pyrrolidine and piperidine derivatives
12/29/1998US5854267 Method for preventing heartburn
12/29/1998US5854263 1- (1,4-benzodioxanyl)alkyl!-3-(heteroaryl) pyrrolidines and related compounds and their therapeutic utility
12/29/1998US5854261 Prokinetic compounds
12/29/1998US5854260 Enterokinetic benzamide
12/29/1998US5854257 Naphthyridinone derivatives
12/29/1998US5854256 Quinuclidine derivatives
12/29/1998US5854255 Therapeutic package for the long term reduction of body fat stores insulin resistance hyperinsulinemia and hyperglycemia in vertebrates
12/29/1998US5854254 Male contraceptives
12/29/1998US5854251 Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
12/29/1998US5854249 Opioid diarylmethylpiperazines and piperidines
12/29/1998US5854248 Nefazodone: use in migraine prophylaxis
12/29/1998US5854247 Piperazine, piperidine and tetrahydropyridine derivatives useful as 5-HT1 recepter agonists
12/29/1998US5854246 Topical ketoconazole emulsions
12/29/1998US5854244 Melamine derivatives for use in the treatment of cancer
12/29/1998US5854243 3-heteroaryl-1-pyrrolidinealkylthiols and derivatives thereof and their therapeutic utility
12/29/1998US5854242 Benzoxazine antimicrobial agents
12/29/1998US5854241 Pyrido 3,2,1-I,J! 3,1!benzoxazine derivatives
12/29/1998US5854240 Methylene blue for the treatment or prophylaxis of encephalopathy caused by ifosfamide
12/29/1998US5854239 Diazabicyclic neuokinin antagonists
12/29/1998US5854238 Use of a thienotriazolodiazephine to increase apolipoprotein A-I levels
12/29/1998US5854235 17-spiromethylene steroids
12/29/1998US5854234 Amidino dervatives useful as nitric oxide synthase inhibitors
12/29/1998US5854233 Method of treating liver disease and like indications with vasodilating agents
12/29/1998US5854232 Acyclic anc cyclic amides as neurotransmitter release enhancers
12/29/1998US5854231 Pharmaceutical composition for inhibiting the growth of cancers
12/29/1998US5854230 Antiandrogenic agents and related pharmaceutical compositions and methods of use
12/29/1998US5854229 Therapeutic methods and delivery systems utilizing sex steroid precursors
12/29/1998US5854226 Pharmaceutical composition
12/29/1998US5854224 Composition and method for delivery of nucleic acids
12/29/1998US5854219 9-N-ethenyl derivatives of 9(S)-erythromycylamine
12/29/1998US5854218 Sialyl Lex analogues as inhibitors of cellular adhesion
12/29/1998US5854213 Antifungal cyclohexapeptides
12/29/1998US5854207 Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
12/29/1998US5854204 Aβ peptides that modulate β-amyloid aggregation
12/29/1998US5854038 Localization of a therapeutic agent in a cell in vitro
12/29/1998US5854036 Sesquiteterpenic dervatives
12/29/1998US5854020 TCSTS polynucleotides